Volume 14, Number 5—May 2008
Dispatch
Fatal Rickettsia conorii subsp. israelensis Infection, Israel
Table
Diagnostic tests performed to identify spotted fever in the patient*
Day after disease onset | Assay | Specimen(s) tested | Result | Laboratory |
---|---|---|---|---|
7 |
IFA
PCR |
Serum
Serum |
IgM<100, IgG<100
Negative |
IIBR†
IIBR |
11 (autopsy) | IFA | Serum | IgM = 64, IgG<32 | CDC‡ |
PCR | Serum sediment Liver, muscle, skin, lung, kidney Liver, muscle, skin | Rickettsia conorii subsp. israelensis Spotted fever group rickettsiae R. conorii subsp. israelensis | CDC IIBR§ CDC¶ | |
IHC stain# | Brain, kidney | Positive | CDC | |
Cell culture** | Liver, lung | Negative | IIBR |
*IFA, immunofluorescent assay; Ig, immunoglobulin; IIBR, Institute for Biological Research; CDC, Centers for Disease Control and Prevention; IHC, immunohistochemical.
†IFA performed (6). Cutoff values for IgM and IgG are 100.
‡IFA performed (7). Cutoff values for IgM and IgG are 64.
§Nested PCR for 17-kDa protein gene (8).
¶Nested and semi-nested PCR for 17 kDa protein gene and recombinant outer membrane protein A gene fragment, respectively, followed by sequencing (9).
#Three-micron sections cut from formalin-fixed, paraffin-embedded brain and kidney tissue samples were stained by using an immunoalkaline phosphatase technique with a hyperimmune rabbit anti–Rickettsia rickettsii antibody at a dilution of <500 (3).
**Homogenized samples from lung and liver were applied by centrifugation onto monolayer of Vero cells culture in 24-well plates and incubated for 2 weeks at 35°C in 5% CO2 atmosphere incubator.
References
- Zhu Y, Fournier PE, Eremeeva M, Raoult D. Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence typing and an emended description of Rickettsia conorii. BMC Microbiol. 2005;5:11. DOIPubMedGoogle Scholar
- Mumcuoglu KY, Keysary A, Gilead L. Mediterranean spotted fever in Israel: a tick-borne disease. Isr Med Assoc J. 2002;4:44–9.PubMedGoogle Scholar
- Paddock CD, Childs JE, Zaki SR, Berger SA. Reply. Mortality in serologically unconfirmed Mediterranean spotted fever. J Infect Dis. 2000;181:810–2. DOIPubMedGoogle Scholar
- Yagupsky P, Wolach B. Fatal Israeli spotted fever in children. Clin Infect Dis. 1993;17:850–3.PubMedGoogle Scholar
- Walker DH. Rickettsial diseases in travelers. Travel Med Infect Dis. 2003;1:35–40. DOIPubMedGoogle Scholar
- Chai JTY, Eremeeva ME. Borland CDR, Karas JA. Fatal Israeli spotted fever in a UK traveler to South Portugal. J Travel Med. 2008;15:122–3. DOIPubMedGoogle Scholar
- Aharonowitz G, Koton S, Segal S, Anis E, Green MS. Epidemiological characteristics of spotted fever in Israel over 26 years. Clin Infect Dis. 1999;29:1321–2. DOIPubMedGoogle Scholar
- Schattner A, Leitner M, Keysary A, Geltner D. Case report: fatal seronegative rickettsial infection diagnosed by the polymerase chain reaction. Am J Med Sci. 1992;303:392–4. DOIPubMedGoogle Scholar
- Keysary A, Potasman I, Itzhaki A, Finkelstein R, Yitzhaki S, Strenger C, Clusters of Mediterranean spotted fever in Israel. Vector Borne Zoonotic Dis. 2007;7:143–6. DOIPubMedGoogle Scholar
- Paddock CD, Koss T, Eremeeva ME, Dasch GA, Zaki SR, Sumner JW. Isolation of Rickettsia akari from eschars of patients with rickettsialpox. Am J Trop Med Hyg. 2006;75:732–8.PubMedGoogle Scholar